Kevin Feeley - Mar 9, 2024 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Devin Schaffer, Attorney-in-Fact
Stock symbol
WGS
Transactions as of
Mar 9, 2024
Transactions value $
$0
Form type
4
Date filed
3/12/2024, 05:27 PM
Previous filing
Mar 5, 2024
Next filing
Mar 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Options Exercise $0 +2.46K +10.5% $0.00 25.9K Mar 9, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Restricted Stock Unit Options Exercise $0 -2.46K -8.33% $0.00 27.1K Mar 9, 2024 Class A Common Stock 2.46K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2 6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.